MENU

Primary tabs

Fox Chase Cancer Center News

Primary tabs

November 8, 2021

Fox Chase Cancer Center Receives Two Press Ganey Patient Experience Awards

PHILADELPHIA (November 8, 2021)—Fox Chase Cancer Center has been recognized for excellence in patient care with two Press Ganey Awards, the Pinnacle of Excellence Award and the Guardian of Excellence Award.

November 8, 2021

In Vino Vita, Fox Chase’s Signature Fundraising Event, Raises Over $1.5 Million for Cancer Research, Treatment and Prevention

PHILADELPHIA (November 8, 2021)—In Vino Vita, Fox Chase Cancer Center’s signature fundraising event, was held on October 30 at the National Constitution Center, and raised over $1.5 million for cancer research, treatment and prevention.

November 4, 2021

Artificial Intelligence Could Have an Impact on Kidney Cancer Management

PHILADELPHIA (November 4, 2021)—As more radiographic, histopathologic, and genomic data are gathered and made accessible, it is only a matter of time until artificial intelligence (AI) becomes part of the regular clinical workflow for treating kidney cancer, according to a review article published by researchers at Fox Chase Cancer Center.

November 3, 2021

Benjamin A. Young Appointed Program Manager at the Marvin & Concetta Greenberg Pancreatic Cancer Institute

PHILADELPHIA (November 3, 2021)—Benjamin A. Young, CCRP, has been appointed Program Manager at the Marvin & Concetta Greenberg Pancreatic Cancer Institute, where he will work with researchers to coordinate the institute’s basic, clinical, and population sciences research programs.

November 2, 2021

Marcin Chwistek to Speak at Hospice Care Professionals Association Conference in Russia

PHILADELPHIA (November 2, 2021)—Marcin Chwistek, MD, FAAHPM, director of the Supportive Oncology and Palliative Care Program at Fox Chase Cancer Center, will be speaking virtually at the Hospice Care Professionals Association Conference being held in Moscow November 2-3.

October 25, 2021

Study Finds Low Risk of Toxicity in Prostate Cancer Patients Treated With Hypofractionated Radiation Therapy

PHILADELPHIA (October 25, 2021)—A multi-institutional retrospective analysis conducted by researchers at Fox Chase Cancer Center has found that early stage prostate cancer patients treated with moderately hypofractionated intensity-modulated radiation therapy or proton beam radiation therapy had low risk of serious late genitourinary and gastrointestinal complications.

October 24, 2021

Fox Chase Researchers Find Pulsed Low-Dose Rate Radiotherapy Shows Improvement Over Standard Twice-Daily Radiation

PHILADELPHIA (October 24, 2021)—In a recent retrospective study, researchers at Fox Chase Cancer Center found anorectal cancer patients reirradiated with pulsed low-dose-rate radiotherapy had reduced toxicity and improved outcomes when compared with patients treated with twice-daily radiotherapy.

October 19, 2021

Fox Chase Researcher Edna Cukierman Appointed Senior Editor on New Journal

PHILADELPHIA (October 19, 2021)—Fox Chase Cancer Center’s Edna “Eti” Cukierman, PhD, co-director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute, has been named a senior editor for Cancer Research Communications, a new online journal.  

Pages

Connect with Fox Chase